Scope Markets has launched pre-IPO contracts for difference tied to indicative prices for Anthropic and OpenAI, while Anthropic is reportedly sticking to its IPO timetable despite recent AI-linked market turbulence. The broker says eligible retail clients can trade long or short around the clock through MetaTrader 5 using instruments ANTHROPIC.24_7 and OPENAI.24_7. The contracts require 100% margin and give clients no shares, IPO allocation or shareholder rights.
Scope says the products derive indicative prices from pre-IPO derivatives markets, but it did not specify the market or data providers behind each quote, update frequency, spread methodology or treatment of disruptions. That matters because there is no continuous public order book for private-company shares. Scope Managing Director John Murphy said the two companies are among the most closely watched in the world and that clients can trade valuation moves long or short at any hour. The broker scheduled educational webinars on November 12, including an Arabic session at 20:00 Riyadh time and an English session at 14:00 GMT.
Scope's structure differs from other pre-IPO products. ThinkMarkets offers an Anthropic contract tied to expected first-day market capitalisation rather than an indicative share price, while Axi advertises leverage of up to 25:1 on pre-IPO perpetuals. Scope states 100% margin, removing leverage but not product risk: clients still face spread, financing, close-out and reference-price uncertainty.
Separately, the Financial Times reported that Anthropic has no plans to postpone its IPO, even after Thursday's sharp selloff in AI-linked stocks. The maker of Claude AI models reportedly continues to target a public listing before Thanksgiving, aiming to raise $80 billion to $100 billion at a valuation between $1.25 trillion and $1.75 trillion. That contrasts with a Wall Street Journal account suggesting some investors questioned whether the company might delay the offering following the AI selloff.
Anthropic filed a public Form S-1 on October 26 for a proposed Nasdaq listing under the ticker ANT. Its November 2 amendment added third-quarter results: revenue of $16.956 billion, up about 47% quarter-on-quarter, compared with 144% sequential growth in Q2. Share count and price range remain undetermined. OpenAI, by contrast, has a confidential IPO filing from June, and CEO Sam Altman said in September that a 2026 listing would be "ill-advised." Neither company has announced a listing date.
On Friday, equity markets partially recovered. The Nasdaq Composite rose 1.1%, helped by gains in Nvidia and Micron, while the S&P 500 added 0.3%. Thursday's session had been Wall Street's worst since April 2025, with the Nasdaq falling 5.5% and entering correction territory. A stronger-than-expected October jobs report also supported sentiment. JPMorgan global market strategist Jordan Jackson said the fundamental backdrop for risk assets remains constructive into year end.
The outcome of Anthropic's listing could influence confidence in large-scale AI equity offerings and fintech adoption of advanced language models. For traders of Scope's new CFDs, however, the key risk remains that they are trading a synthetic derivative, not owning either business.
